Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Clinical · Molecular biology · Bioinfo & AI

Latent Class Analysis-Derived Classification and Cancer-Specific Death in Endometrial Carcinoma: A Population-Based Cohort Study

Summary

This study developed a novel clinical classification for endometrial carcinoma (EC) using latent class analysis (LCA) on a large cohort of 46,772 cases from the SEER program. Five clinically interpretable classes emerged, each associated with distinct risks of cancer-specific mortality (CSM) and TCGA molecular subtypes. Integrating this LCA classification into molecular survival models improved prognostic discrimination. Furthermore, class-specific transcriptomic signatures involving metabolic reprogramming, DNA repair, and immune pathways were identified. The benefits of combined treatments (surgery, radiotherapy, chemotherapy) varied significantly by class, suggesting a more personalized therapeutic approach.

Critical appraisal

Clinical. This large-scale population-based cohort study (46,772 cases) provides a robust prognostic classification for endometrial carcinoma, complementing existing molecular classifications. The LCA’s ability to identify subgroups with significantly different cancer-specific mortality risks (e.g., Class 4 with a subdistribution hazard ratio of 1.34) and distinct responses to combined treatments has immediate clinical impact. This justifies clinical trials to validate these personalized treatment strategies and could potentially change clinical practice guidelines within 3-5 years by enabling targeted de-escalation or escalation of therapy.

Molecular biology. The LCA classification, although derived from clinical variables, was associated with TCGA molecular subtypes (e.g., Class 3 with CN-high and Class 1 with CN-low subtypes). Transcriptomic analysis revealed class-specific signatures implicating metabolic reprogramming, DNA repair, and immune pathways. These discoveries provide a mechanistic basis for the observed clinical differences and could identify novel biomarkers or therapeutic targets, leading to the development of complementary molecular tests.

Bioinfo & AI. The study employed Latent Class Analysis (LCA), a statistical method to identify unobserved subgroups within complex data, applied here to 46,772 endometrial carcinoma cases from the SEER program. The approach is novel in its application to integrate demographic, clinicopathologic features, cancer-specific mortality, and molecular landscapes. The mapping of LCA classes to TCGA data and the improvement in C-index for survival models demonstrate the validity and utility of this classification. Clinical deployment of this algorithm could aid in prognostic patient stratification and treatment decision-making, complementing existing molecular classifications.

The summary and the appraisal were written by a language model from the title and abstract of the original article. A curator decided to publish it. Methodology